Autopsy report · NCT07165756

"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.

“Principal Investigator's departure”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 11 months before it stopped.
• 34 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Institut de Cancérologie de Lorraine

Sponsor type

University, hospital or other

Conditions

Localized Breast Cancer

Participants

34

Sites

1

Countries

France

Trials that died the same way

• Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)
  “Departure of the Principal Investigator” (98% match in meaning)
• Interest of Virtual Reality for the Management of Hospitalized Pregnant Patients at Risk of Preterm Delivery
  “departure of the principal investigator without replacement” (90% match in meaning)
• Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion
  “Departure of the principal investigator and lack of succession” (89% match in meaning)
• Preoxygenation Before Prehospital Tracheal Intubation With NIV Versus Balloon
  “departure without replacement of the principal investigator” (88% match in meaning)
• Fast Track for Wrist and Scaphoid Fractures
  “Investigator's departure” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.